
doi: 10.1038/447629a
pmid: 17554281
Support for copycat versions of biotechnology drugs is growing quickly in the US Congress. Meredith Wadman reports.
Drug Industry, Drugs, Generic, Humans, Drug Costs, Biotechnology
Drug Industry, Drugs, Generic, Humans, Drug Costs, Biotechnology
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 1 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
